Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Atorvastatin for the Treatment of Lithium-Induced Nephrogenic Diabetes Insipidus: A Randomized Controlled Trial

NCT02967653 is registered in ClinicalTrials.gov with Lady Davis Institute as lead sponsor.

NCT NCT02967653
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02967653 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Atorvastatin for the Treatment of Lithium-Induced Nephrogenic Diabetes Insipidus: A Randomized Controlled Trial
Lead sponsor
Lady Davis Institute
Phase
Phase 2
Overall status
Completed
Start date
July 13, 2017
Completion date
July 1, 2019
Enrollment
60 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

lithium use, nephrogenic diabetes insipidus